Javier Martinez-Trufero

19PUBLICATIONS
84CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersSolid tumoursPalliative careMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Mar 12, 2026
Safety and Efficacy of Epirubicin, Ifosfamide, and Nivolumab as First-Line Treatment for Patients with Undifferentiated Pleomorphic Sarcoma.

Javier Martin-Broto, Javier Martinez-Trufero, Roberto Diaz-Beveridge

|Dec 31, 2025
VEGF Signaling Pathway Germline Polymorphisms as Prognostic Pharmacogenetic Biomarkers in Localized High-Grade Osteosarcoma Patients from the GEIS-33 Protocol.

Juliana Salazar, María J Arranz, Javier Martin-Broto

|Oct 16, 2025
Diagnosis and Therapy of Soft Tissue Sarcomas: Spanish Group for Research in Sarcomas (GEIS) Guidelines.

Maria Angeles Vaz-Salgado, Claudia Valverde-Morales, Rosa Alvarez

|Feb 24, 2025
Does Adjuvant Mitotane Impact Cure Rates in Adrenocortical Carcinoma? Insights From the ICARO-GETTHI/SEEN Registry.

Alberto Carmona-Bayonas, Cristina Álvarez-Escolá, Inmaculada Ballester Navarro

|Jan 08, 2025
Pharmacogenetics of Neoadjuvant MAP Chemotherapy in Localized Osteosarcoma: A Study Based on Data from the GEIS-33 Protocol.

Juliana Salazar, María J Arranz, Javier Martin-Broto

|Nov 14, 2024
Nivolumab and sunitinib in patients with advanced bone sarcomas: A multicenter, single-arm, phase 2 trial.

Emanuela Palmerini, Antonio Lopez Pousa, Giovanni Grignani

Pageof 4

Frequent Collaborators

9 joint publications

Javier Martin-Broto

5 joint publications

Nadia Hindi

5 joint publications

Rosa Álvarez

4 joint publications

David S Moura